Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at JMP Securities from $110.00 to $106.00. They now have a "market outperform" rating on the stock.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $107.00 to $106.00. They now have an "outperform" rating on the stock.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $108.00 price target on the stock.
Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]